The Investigation of Associations between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344, <i>EGFR</i> rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis
Breast cancer is one of the most common oncological diseases among women worldwide. Cell cycle and apoptosis—related genes <i>TP53</i>, <i>BBC3</i>, <i>CCND1</i> and <i>EGFR</i> play an important role in the pathogenesis of breast cancer. However, the...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/8/1419 |
id |
doaj-905692a5b9a64961ba69b088fa6aa49b |
---|---|
record_format |
Article |
spelling |
doaj-905692a5b9a64961ba69b088fa6aa49b2021-08-26T13:40:18ZengMDPI AGDiagnostics2075-44182021-08-01111419141910.3390/diagnostics11081419The Investigation of Associations between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344, <i>EGFR</i> rs2227983 Polymorphisms and Breast Cancer Phenotype and PrognosisJustina Bekampytė0Agnė Bartnykaitė1Aistė Savukaitytė2Rasa Ugenskienė3Erika Korobeinikova4Jurgita Gudaitienė5Elona Juozaitytė6Oncology Research Laboratory, Oncology Institute, Lithuanian University of Health Sciences, LT-50161 Kaunas, LithuaniaOncology Research Laboratory, Oncology Institute, Lithuanian University of Health Sciences, LT-50161 Kaunas, LithuaniaOncology Research Laboratory, Oncology Institute, Lithuanian University of Health Sciences, LT-50161 Kaunas, LithuaniaOncology Research Laboratory, Oncology Institute, Lithuanian University of Health Sciences, LT-50161 Kaunas, LithuaniaDepartment of Oncology and Hematology, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, LT-50161 Kaunas, LithuaniaDepartment of Oncology and Hematology, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, LT-50161 Kaunas, LithuaniaDepartment of Oncology and Hematology, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, LT-50161 Kaunas, LithuaniaBreast cancer is one of the most common oncological diseases among women worldwide. Cell cycle and apoptosis—related genes <i>TP53</i>, <i>BBC3</i>, <i>CCND1</i> and <i>EGFR</i> play an important role in the pathogenesis of breast cancer. However, the roles of single nucleotide polymorphisms (SNPs) in these genes have not been fully defined. Therefore, this study aimed to analyze the association between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344 and <i>EGFR</i> rs2227983 polymorphisms and breast cancer phenotype and prognosis. For the purpose of the analysis, 171 Lithuanian women were enrolled. Genomic DNA was extracted from peripheral blood; PCR-RFLP was used for SNPs analysis. The results showed that <i>BBC3</i> rs2032809 was associated with age at the time of diagnosis, disease progression, metastasis and death. <i>CCND1</i> rs9344 was associated with tumor size, however an association resulted in loss of significance after Bonferroni correction. In survival analysis, significant associations were observed between <i>BBC3</i> rs2032809 and OS, PFS and MFS. <i>EGFR</i> rs2227983 also showed some associations with OS and PFS (univariate Cox regression analysis). However, the results were in loss of significance (multivariate Cox regression analysis). In conclusion, <i>BBC3</i> rs2032809 polymorphism was associated with breast cancer phenotype and prognosis. Therefore, it could be applied as potential markers for breast cancer prognosis.https://www.mdpi.com/2075-4418/11/8/1419breast cancerSNP<i>TP53</i><i>BBC3</i><i>CCND</i><i>EGFR</i> |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Justina Bekampytė Agnė Bartnykaitė Aistė Savukaitytė Rasa Ugenskienė Erika Korobeinikova Jurgita Gudaitienė Elona Juozaitytė |
spellingShingle |
Justina Bekampytė Agnė Bartnykaitė Aistė Savukaitytė Rasa Ugenskienė Erika Korobeinikova Jurgita Gudaitienė Elona Juozaitytė The Investigation of Associations between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344, <i>EGFR</i> rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis Diagnostics breast cancer SNP <i>TP53</i> <i>BBC3</i> <i>CCND</i> <i>EGFR</i> |
author_facet |
Justina Bekampytė Agnė Bartnykaitė Aistė Savukaitytė Rasa Ugenskienė Erika Korobeinikova Jurgita Gudaitienė Elona Juozaitytė |
author_sort |
Justina Bekampytė |
title |
The Investigation of Associations between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344, <i>EGFR</i> rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis |
title_short |
The Investigation of Associations between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344, <i>EGFR</i> rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis |
title_full |
The Investigation of Associations between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344, <i>EGFR</i> rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis |
title_fullStr |
The Investigation of Associations between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344, <i>EGFR</i> rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis |
title_full_unstemmed |
The Investigation of Associations between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344, <i>EGFR</i> rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis |
title_sort |
investigation of associations between <i>tp53</i> rs1042522, <i>bbc3</i> rs2032809, <i>ccnd1</i> rs9344, <i>egfr</i> rs2227983 polymorphisms and breast cancer phenotype and prognosis |
publisher |
MDPI AG |
series |
Diagnostics |
issn |
2075-4418 |
publishDate |
2021-08-01 |
description |
Breast cancer is one of the most common oncological diseases among women worldwide. Cell cycle and apoptosis—related genes <i>TP53</i>, <i>BBC3</i>, <i>CCND1</i> and <i>EGFR</i> play an important role in the pathogenesis of breast cancer. However, the roles of single nucleotide polymorphisms (SNPs) in these genes have not been fully defined. Therefore, this study aimed to analyze the association between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344 and <i>EGFR</i> rs2227983 polymorphisms and breast cancer phenotype and prognosis. For the purpose of the analysis, 171 Lithuanian women were enrolled. Genomic DNA was extracted from peripheral blood; PCR-RFLP was used for SNPs analysis. The results showed that <i>BBC3</i> rs2032809 was associated with age at the time of diagnosis, disease progression, metastasis and death. <i>CCND1</i> rs9344 was associated with tumor size, however an association resulted in loss of significance after Bonferroni correction. In survival analysis, significant associations were observed between <i>BBC3</i> rs2032809 and OS, PFS and MFS. <i>EGFR</i> rs2227983 also showed some associations with OS and PFS (univariate Cox regression analysis). However, the results were in loss of significance (multivariate Cox regression analysis). In conclusion, <i>BBC3</i> rs2032809 polymorphism was associated with breast cancer phenotype and prognosis. Therefore, it could be applied as potential markers for breast cancer prognosis. |
topic |
breast cancer SNP <i>TP53</i> <i>BBC3</i> <i>CCND</i> <i>EGFR</i> |
url |
https://www.mdpi.com/2075-4418/11/8/1419 |
work_keys_str_mv |
AT justinabekampyte theinvestigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis AT agnebartnykaite theinvestigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis AT aistesavukaityte theinvestigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis AT rasaugenskiene theinvestigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis AT erikakorobeinikova theinvestigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis AT jurgitagudaitiene theinvestigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis AT elonajuozaityte theinvestigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis AT justinabekampyte investigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis AT agnebartnykaite investigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis AT aistesavukaityte investigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis AT rasaugenskiene investigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis AT erikakorobeinikova investigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis AT jurgitagudaitiene investigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis AT elonajuozaityte investigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis |
_version_ |
1721194041283969024 |